|
Favorable long-term outcome of patients with 13q deletion and aplastic anemia
|
Jan 2013
|
Haematologica
|
aplastic anemia
|
|
High-Dose Cyclophosphamide in Comparison with Antithymocyte Globulin for Treatment of Acquired Severe Aplastic Anemia
|
Jan 2013
|
Exp Hematol
|
aplastic anemia
|
|
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
|
Jan 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
New Strategies in Myelodysplastic Syndromes: Application of molecular diagnostics to clinical practice.
|
Jan 2013
|
Clin Cancer Res
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms.
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
|
Jan 2013
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
|
Jan 2013
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
|
Jan 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Heterogeneity in the Myelodysplastic Syndromes: Moving Toward a Better Understanding
|
Jan 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Leukemia as a Cause of Death among Patients with Myelodysplastic Syndromes (MDS) in a Population- Based Cancer Registry: Improving Estimates of MDS-Related Mortality in the Population.
|
Jan 2013
|
J Registry Manag
|
myelodysplastic syndromes (MDS)
|
